Toggle navigation
Home
Search
Services
Blog
Contact
About
Molecular Approach to Hypothalamic Rhythms
Erlander, Mark G.
Scripps Research Institute, La Jolla, CA, United States
Search grants from Mark Erlander
Search grants from Scripps Research Institute
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Integrated Technology-Based Intervention to Reduce Heavy Drinking and Chronic Pain among Patients in Primary Care
Utilizing Precision Medicine to elucidate the mechanisms underpinning treatment efficacy
Estrogen Signaling in a Mouse Model for Lymphangioleiomyomatosis
A Limited-angle Intra-fractional Verification (LIVE) System for SBRT Treatments
Nitric Oxide and Hereditary Low-Renin Hypertension
Recently added grants:
Neutrophil plasticity in autoimmune disease
Enhance Arthroplasty Research through Electronic Health Records and Nlp-Enabled Informatics
H. pylori-induced Inflammation and Gastric Cancer
Understanding the mechanism of action for anticancer sulfonamides that target splicing
Directing the metabolic fate of CAR T cells
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Postdoctoral Individual National Research Service Award (F32)
Project #
1F32NS009142-01
Application #
3056079
Study Section
Biological Sciences 2 (BIOL)
Project Start
1992-03-23
Project End
Budget Start
1991-12-01
Budget End
1992-11-30
Support Year
1
Fiscal Year
1991
Total Cost
Indirect Cost
Institution
Name
Scripps Research Institute
Department
Type
DUNS #
City
La Jolla
State
CA
Country
United States
Zip Code
92037
Related projects
NIH 1993
F32 NS
Molecular Approach to Hypothalamic Rhythms
Erlander, Mark G. / Scripps Research Institute
NIH 1991
F32 NS
Molecular Approach to Hypothalamic Rhythms
Erlander, Mark G. / Scripps Research Institute
Comments
Be the first to comment on Mark Erlander's grant